To consolidate the above analyses using the Oncomine datasets, we examined SIPL1 protein expression by immunohistochemistry (IHC) using a tissue microarray containing 206 cases of primary breast cancers (S2 Table). This evidence concerns the gene SHARPIN and breast carcinoma.